Litigator of the Week: Jay Lefkowitz of Kirkland & Ellis

, The Litigation Daily

   | 0 Comments

Big Pharma and the antitrust bar both have a lot at stake as the Supreme Court considers what to do about "pay for delay" deals that keep generic drugs off the market. In the meantime, Lefkowitz won a ruling on pay-for-delay that gives the pharmaceutical industry some crucial breathing room where it needed it most, in the Third Circuit.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202581474641

Thank you!

This article's comments will be reviewed.